Analystreport

Anavex Life Sciences (AVXL) was upgraded by Weiss Ratings from "sell (e+)" to "sell (d-)".

Anavex Life Sciences Corp.  (AVXL) 
NASDAQ:AMEX Investor Relations: anavex.com/share-data